The impact of metformin in chronic kidney disease-mineral and bone disorder
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a disorder of mineral and bone metabolism due to chronic kidney disease (CKD). Bone disease and mortality are more common in patients with CKD. In addition of antidiabetic properties of metformin (MET), it possesses anti-inflammatory, ant...
Guardado en:
Autores principales: | Rohollah Masumi, Ramin Tolouian, Audrey Tolouian, Leila Mohmoodnia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Society of Diabetic Nephropathy Prevention
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9185892ed5da41f999553db70b8a8210 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Herbal antioxidants and renal ischemic-reperfusion injury; an updated review
por: Masoumeh Asgharpour, et al.
Publicado: (2021) -
Association between metabolic parameters and risks of anemia and electrolyte disturbances among stages 3–5 chronic kidney disease patients in Taiwan
por: Adi Lukas Kurniawan, et al.
Publicado: (2021) -
Perspectives on the relationship of renal disease and coronavirus disease 2019
por: Banafsheh Yalameha, et al.
Publicado: (2020) -
[51] The horseshoe kidney: Pathological and therapeutic aspects
por: Megri Rochdi, et al.
Publicado: (2018) -
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
por: Yin Li, et al.
Publicado: (2021)